BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38277754)

  • 21. Redefining the R1 resection in patients with pancreatic ductal adenocarcinoma.
    Markov P; Satoi S; Kon M
    J Hepatobiliary Pancreat Sci; 2016 Sep; 23(9):523-32. PubMed ID: 27524388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case-matched comparison study of total pancreatectomy versus pancreaticoduodenectomy for patients with pancreatic ductal adenocarcinoma.
    Xiong J; Wei A; Ke N; He D; Chian SK; Wei Y; Hu W; Liu X
    Int J Surg; 2017 Dec; 48():134-141. PubMed ID: 29081373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of at least 1 mm as cut-off for resection margins for pancreatic adenocarcinoma of the body and tail.
    Hank T; Hinz U; Tarantino I; Kaiser J; Niesen W; Bergmann F; Hackert T; Büchler MW; Strobel O
    Br J Surg; 2018 Aug; 105(9):1171-1181. PubMed ID: 29738626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes of Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma in the Netherlands: A Nationwide Retrospective Analysis.
    de Rooij T; Tol JA; van Eijck CH; Boerma D; Bonsing BA; Bosscha K; van Dam RM; Dijkgraaf MG; Gerhards MF; van Goor H; van der Harst E; de Hingh IH; Kazemier G; Klaase JM; Molenaar IQ; Patijn GA; van Santvoort HC; Scheepers JJ; van der Schelling GP; Sieders E; Busch OR; Besselink MG;
    Ann Surg Oncol; 2016 Feb; 23(2):585-91. PubMed ID: 26508153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distal Bile Duct Cancer: Radical (R0 > 1 mm) Resection Achieves Favorable Survival.
    Tjaden C; Hinz U; Klaiber U; Heger U; Springfeld C; Goeppert B; Schmidt T; Mehrabi A; Strobel O; Berchtold C; Schneider M; Diener M; Neoptolemos JP; Hackert T; Büchler MW
    Ann Surg; 2023 Jan; 277(1):e112-e118. PubMed ID: 34171863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of extent of pancreatic and venous resection on survival for patients with pancreatic cancer.
    Serenari M; Ercolani G; Cucchetti A; Zanello M; Prosperi E; Fallani G; Masetti M; Lombardi R; Cescon M; Jovine E
    Hepatobiliary Pancreat Dis Int; 2019 Aug; 18(4):389-394. PubMed ID: 31230959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor infiltration in the medial resection margin predicts survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
    Zhang Y; Frampton AE; Cohen P; Kyriakides C; Bong JJ; Habib NA; Spalding DR; Ahmad R; Jiao LR
    J Gastrointest Surg; 2012 Oct; 16(10):1875-82. PubMed ID: 22878786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive factors for long-term survival after surgery for pancreatic ductal adenocarcinoma: Making a case for standardized reporting of the resection margin using certified cancer center data.
    Weyhe D; Obonyo D; Uslar VN; Stricker I; Tannapfel A
    PLoS One; 2021; 16(3):e0248633. PubMed ID: 33735191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of resection margin status on survival after operation for pancreatic head cancer with extrapancreatic nerve plexus invasion.
    Konishi T; Takano S; Furukawa K; Takayashiki T; Kuboki S; Suzuki D; Sakai N; Hosokawa I; Mishima T; Ohtsuka M
    J Surg Oncol; 2022 Nov; 126(6):1038-1047. PubMed ID: 35796724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microscopically positive (R1) resections do not affect survival in pancreatic head cancer.
    Mois E; Graur F; Al-Hajjar N; Zaharie F; Bartos A; Bodea R; Zaharie T; Rusu I; Iancu C
    Ann Ital Chir; 2017; 88():491-496. PubMed ID: 29339587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of resection margin status on survival in advanced N stage pancreatic cancer - a multi-institutional analysis.
    Teske C; Stimpel R; Distler M; Merkel S; Grützmann R; Bolm L; Wellner U; Keck T; Aust DE; Weitz J; Welsch T
    Langenbecks Arch Surg; 2021 Aug; 406(5):1481-1489. PubMed ID: 33712875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting Surgical Margins in Patients With Borderline Resectable and Locally Advanced Pancreatic Cancer Undergoing Resection.
    Ren W; Xourafas D; Ashley SW; Clancy TE
    Am Surg; 2022 Dec; 88(12):2899-2906. PubMed ID: 33861651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. R1 resection in pancreatic cancer has significant impact on long-term outcome in standardized pathology modified for routine use.
    Rau BM; Moritz K; Schuschan S; Alsfasser G; Prall F; Klar E
    Surgery; 2012 Sep; 152(3 Suppl 1):S103-11. PubMed ID: 22766366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathological Margin Clearance and Survival After Pancreaticoduodenectomy in a US and European Pancreatic Center.
    van Roessel S; Kasumova GG; Tabatabaie O; Ng SC; van Rijssen LB; Verheij J; Najarian RM; van Gulik TM; Besselink MG; Busch OR; Tseng JF
    Ann Surg Oncol; 2018 Jun; 25(6):1760-1767. PubMed ID: 29651577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Presence of low-grade IPMN at the pancreatic transection margin does not have prognostic significance after resection of IPMN-associated pancreatic adenocarcinoma.
    Leonhardt CS; Hinz U; Kaiser J; Hank T; Tjaden C; Bergmann F; Hackert T; Büchler MW; Strobel O
    Eur J Surg Oncol; 2023 Jan; 49(1):113-121. PubMed ID: 35965217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of margin status determined by the one-millimeter rule on tumor recurrence and survival following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
    Nitta T; Nakamura T; Mitsuhashi T; Asano T; Okamura K; Tsuchikawa T; Tamoto E; Murakami S; Noji T; Kurashima Y; Ebihara Y; Nakanishi Y; Shichinohe T; Hirano S
    Surg Today; 2017 Apr; 47(4):490-497. PubMed ID: 27677294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is distal pancreatectomy with en-bloc celiac axis resection effective for patients with locally advanced pancreatic ductal adenocarcinoma? -Multicenter surgical group study.
    Yamamoto T; Satoi S; Kawai M; Motoi F; Sho M; Uemura KI; Matsumoto I; Honda G; Okada KI; Akahori T; Toyama H; Kurata M; Yanagimoto H; Yamaue H; Unno M; Kon M; Murakami Y
    Pancreatology; 2018 Jan; 18(1):106-113. PubMed ID: 29153701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intraoperative Pancreatic Neck Margin Assessment During Pancreaticoduodenectomy for Pancreatic Adenocarcinoma in the Era of Neoadjuvant Therapy: A Multi-institutional Analysis from the Central Pancreatic Consortium.
    Kelly KN; Macedo FI; Seaton M; Wilson G; Hammill C; Martin RC; Maduekwe UN; Kim HJ; Maithel SK; Abbott DE; Ahmad SA; Kooby DA; Merchant NB; Datta J
    Ann Surg Oncol; 2022 Sep; 29(9):6004-6012. PubMed ID: 35511392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Margin Status on Survival in Patients with Pancreatic Ductal Adenocarcinoma Receiving Neoadjuvant Chemotherapy.
    Schmocker RK; Delitto D; Wright MJ; Ding D; Cameron JL; Lafaro KJ; Burns WR; Wolfgang CL; Burkhart RA; He J
    J Am Coll Surg; 2021 Apr; 232(4):405-413. PubMed ID: 33338577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of adjacent organ resection in patients with left-sided pancreatic ductal adenocarcinoma following distal pancreatectomy.
    Song KB; Kwon J; Kim YW; Hwang DW; Lee JH; Hong S; Lee JW; Hwang K; Yoo D; Kim SC
    J Hepatobiliary Pancreat Sci; 2019 Jun; 26(6):227-234. PubMed ID: 30980486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.